These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 1910280)
1. A single-step separation of the one- and two-chain forms of tissue plasminogen activator. Husain SS Arch Biochem Biophys; 1991 Mar; 285(2):373-6. PubMed ID: 1910280 [TBL] [Abstract][Full Text] [Related]
2. Localization of the binding sites of porcine tissue-type plasminogen activator and plasminogen to heparin. Soeda S; Kakiki M; Shimeno H; Nagamatsu A Biochim Biophys Acta; 1987 Dec; 916(3):279-87. PubMed ID: 3120775 [TBL] [Abstract][Full Text] [Related]
3. Plasminogen activator inhibitor type-1 interacts exclusively with the proteinase domain of tissue plasminogen activator. Björquist P; Brohlin M; Ehnebom J; Ericsson M; Kristiansen C; Pohl G; Deinum J Biochim Biophys Acta; 1994 Dec; 1209(2):191-202. PubMed ID: 7811690 [TBL] [Abstract][Full Text] [Related]
4. The effector roles of kringle 1 and kringle 2 in the enzymatic properties of recombinant tissue-type plasminogen activator as revealed by generation of recombinant molecules containing each kringle linked to the protease domain. Rydzewski A; Castellino FJ Arch Biochem Biophys; 1993 Jan; 300(1):472-82. PubMed ID: 8424682 [TBL] [Abstract][Full Text] [Related]
5. Kinetic analysis of the interactions between plasminogen activator inhibitor 1 and both urokinase and tissue plasminogen activator. Hekman CM; Loskutoff DJ Arch Biochem Biophys; 1988 Apr; 262(1):199-210. PubMed ID: 3128176 [TBL] [Abstract][Full Text] [Related]
6. Integrin-specific tissue-type plasminogen activator engineered by introduction of the Arg-Gly-Asp sequence. Yamada T; Shimada Y; Kikuchi M Biochem Biophys Res Commun; 1996 Nov; 228(2):306-11. PubMed ID: 8920910 [TBL] [Abstract][Full Text] [Related]
7. A refined kinetic analysis of plasminogen activation by recombinant bovine tissue-type plasminogen activator indicates two interconvertible activator forms. Johnsen LB; Ravn P; Berglund L; Petersen TE; Rasmussen LK; Heegaard CW; Rasmussen JT; Benfeldt C; Fedosov SN Biochemistry; 1998 Sep; 37(36):12631-9. PubMed ID: 9730836 [TBL] [Abstract][Full Text] [Related]
8. Glycosylation variant analysis of recombinant human tissue plasminogen activator produced in urea-cycle-enzyme-expressing Chinese hamster ovary (CHO) cell line. Kim HJ; Kim HJ J Biosci Bioeng; 2006 Nov; 102(5):447-51. PubMed ID: 17189173 [TBL] [Abstract][Full Text] [Related]
9. The effect of polymerised fibrin on the catalytic activities of one-chain tissue-type plasminogen activator as revealed by an analogue resistant to plasmin cleavage. Petersen LC; Johannessen M; Foster D; Kumar A; Mulvihill E Biochim Biophys Acta; 1988 Feb; 952(3):245-54. PubMed ID: 2962643 [TBL] [Abstract][Full Text] [Related]
10. Analysis of tissue plasminogen activator specificity using peptidyl fluorogenic substrates. Butenas S; Kalafatis M; Mann KG Biochemistry; 1997 Feb; 36(8):2123-31. PubMed ID: 9047311 [TBL] [Abstract][Full Text] [Related]
11. Immunoaffinity purification of tissue plasminogen activator from serum-supplemented conditioned media using monoclonal antibody. Reagan ME; Robb M; Bornstein I; Niday EG Thromb Res; 1985 Oct; 40(1):1-9. PubMed ID: 3937281 [TBL] [Abstract][Full Text] [Related]
12. Isolation and preliminary characterisation of active B-chain of recombinant tissue-type plasminogen activator. Dodd I; Fears R; Robinson JH Thromb Haemost; 1986 Feb; 55(1):94-7. PubMed ID: 3085269 [TBL] [Abstract][Full Text] [Related]
13. Current status of activity assays for tissue plasminogen activator. Tang JC; Li S; McGray P; Vecchio A Ann N Y Acad Sci; 1984; 434():536-40. PubMed ID: 6441502 [TBL] [Abstract][Full Text] [Related]
14. Characterisation of the complex of plasminogen activator inhibitor type 1 with tissue-type plasminogen activator by mass spectrometry and size-exclusion chromatography. Strömqvist M; Karlsson KE; Björquist P; Andersson JO; Byström M; Hansson L; Johansson T; Deinum J Biochim Biophys Acta; 1996 Jun; 1295(1):103-9. PubMed ID: 8679667 [TBL] [Abstract][Full Text] [Related]
15. Glycosylation at Asn-184 inhibits the conversion of single-chain to two-chain tissue-type plasminogen activator by plasmin. Wittwer AJ; Howard SC Biochemistry; 1990 May; 29(17):4175-80. PubMed ID: 2141793 [TBL] [Abstract][Full Text] [Related]
16. Stimulation of the amidolytic activity of single chain tissue-type plasminogen activator by fibrinogen degradation products: possible fibrin binding sites on single chain tissue-type plasminogen activator molecule. Urano T; Takada Y; Takada A Biochim Biophys Acta; 1991 Apr; 1077(3):245-52. PubMed ID: 1903067 [TBL] [Abstract][Full Text] [Related]
17. Kinetics of the inhibition of plasminogen activators by the plasminogen-activator inhibitor. Evidence for 'second-site' interactions. Chmielewska J; Rånby M; Wiman B Biochem J; 1988 Apr; 251(2):327-32. PubMed ID: 3135797 [TBL] [Abstract][Full Text] [Related]
19. Novel biomimetic affinity ligands for human tissue plasminogen activator. Wu F; Yu J; Li R Biochem Biophys Res Commun; 2007 Apr; 355(3):673-8. PubMed ID: 17307143 [TBL] [Abstract][Full Text] [Related]
20. Purification of active human plasminogen activator inhibitor 1 from Escherichia coli. Comparison with natural and recombinant forms purified from eucaryotic cells. Lawrence D; Strandberg L; Grundström T; Ny T Eur J Biochem; 1989 Dec; 186(3):523-33. PubMed ID: 2514093 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]